SecBot SecBot
8-K ·Filed Sep 24, 2026

BRVO

Bravo Multinational Inc.
NEUTRAL
Impact 6/10
Horizonweeks Processed1mo ago SEC0001091818-26-000148
Killer combo: Material agreement + unregistered equity (likely PIPE/convertible)
Actionable Insight • Neutral

Monitor the October 5, 2026 deadline for the $400,000 cash payment — if MWP fails to pay, 205,128 preferred shares (12.7% of the issuance) are automatically forfeited, which would reduce the potential dilution and signal a weaker commitment. Also watch for any subsequent filings (S-3, 424B) that register the conversion shares for resale, which would accelerate dilution.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+20d
BRVO ▼ -36.67% at T+20d
NEUTRAL call -36.67% · α vs SPY -35.19% · entry $0.0300 → $0.0190
Next anchor: T+60d in 7w
Entry = T+0 close
Sep 24, 2026
via day close
T+1d
+10.00%
call +10.00% · α +10.74%
$0.0330
settled 5w ago
T+5d
+10.00%
call +10.00% · α +10.22%
$0.0330
settled 26d ago
T+20d
-36.67%
call -36.67% · α -35.19%
$0.0190
settled 5d ago
T+60d
Pending
in 7w

Price Chart

Loading chart...

Executive Summary

Bravo Multinational Inc. executed a transformative capital raise and change of control transaction with MWP Entertainment Group, LLC. The company issued 1,621,026 shares of Series A Preferred Stock (each convertible into 100 common shares) for total consideration of $3,161,000, consisting of a $400,000 cash investment, forgiveness of a $261,000 loan, and a perpetual, perpetual, worldwide, fully paid-up, royalty-free license of content and streaming platform technology valued at $2,500,000. The board was reconstituted with Michael Williams as Chairman and four other directors, and a shareholder rights plan (poison pill) was adopted with a 15% threshold, exempting MWP. A 2026 Stock Incentive Plan reserving 33,000,000 common shares was also approved. This filing bundles a change of control, significant dilution via convertible preferred stock, a new equity incentive plan, and a poison pill — a complex set of events that is net neutral for the common stock given the massive dilution and control shift.

Key Financial Metrics

Deal Value
$3.2M
Offering Size
$3.2M

Key Facts

  • MWP Entertainment Group invested $400,000 cash, forgave a $261,000 loan, and contributed perpetual content/software licenses valued at $2,500,000 for total consideration of $3,161,000.
  • In exchange, Bravo issued 1,621,026 shares of Series A Preferred Stock, each convertible into 100 common shares — representing potential dilution of up to 162,102,600 common shares.
  • The board was reconstituted to five directors: Michael Williams (Chairman), Grant Cramer, Richard Kaiser, Jordan Fiksenbaum, and Steven Marshall.
  • A shareholder rights plan (poison pill) was adopted with a 15% beneficial ownership trigger, exempting MWP and its affiliates.
  • A 2026 Stock Incentive Plan was approved, reserving 33,000,000 common shares for future equity awards.
  • The cash investment of $400,000 is due by October 5, 2026; if not paid, 205,128 preferred shares will be automatically forfeited.

Financial Impact

Total consideration of $3,161,000 for 1,621,026 Series A Preferred shares (each convertible into 100 common shares), implying a per-common-share price of $0.0195. The cash component is only $400,000; the bulk is non-cash license value and debt forgiveness.

dilutioncapital_structurecontrol

Risk Factors

  • Massive potential dilution: 1,621,026 Series A Preferred shares convertible into 162,102,600 common shares, dwarfing the current common share count.
  • The poison pill exempts MWP, entrenching the new controlling shareholder and potentially deterring other bidders.
  • The company's ability to generate revenue from the licensed content/software is unproven; the $2,500,000 license valuation is a non-cash contribution with no guaranteed returns.
  • If the $400,000 cash payment is not made by October 5, 2026, it could signal financial strain at MWP or a renegotiation of terms.

Investment Themes

Services

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001091818-26-000148
Exhibit: ex41.htm0001091818-26-000148
Exhibit: ex101.htm0001091818-26-000148
Exhibit: ex102.htm0001091818-26-000148
Exhibit: ex103.htm0001091818-26-000148
4 reports for BRVO
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for BRVO — sortable, filterable
TypeNow
Oct 6, 2026
20d ago
3
NEUTRAL ★ 1/10
$0.0290 $0.0300▲ +3.45%▲ +4.43%$0.0190 (−34.48%)
Oct 6, 2026
20d ago
SC 13D
NEUTRAL ★ 6/10
$0.0290 $0.0300▲ +3.45%▲ +4.43%$0.0190 (−34.48%)
Oct 6, 2026
20d ago
SC 13D/A
BEARISH ★ 7/10
$0.0290 $0.0290· 0.00%▼ −0.14%$0.0190 (+34.48%)
Sep 24, 2026
4w ago
8-K
NEUTRAL ★ 6/10
$0.0300 $0.0330▲ +10.00%▲ +10.22%$0.0190 (−36.67%)
Showing 4 of 4

US Market Status

Market Open — Closes in 3h 45m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 24, 2026